Debra Richman

The Oncology Institute

Debra Richman serves as Chief Development Officer at The Oncology Institute (NASDAQ: TOI), the nation’s leading provider of value-based oncology care. As Chief Development Officer, she directs The Oncology Institute’s national business and corporate development including strategy, M&A, payor and provider contracting, and new market and product expansion.Debra brings deep expertise in management, scaling revenue, developing, and executing growth-oriented strategic plans, forging accretive partnerships, and new market and product development across industry sectors, including payors, providers, consum

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved